{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:08:12Z","timestamp":1790644092742,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,2,28]],"date-time":"2015-02-28T00:00:00Z","timestamp":1425081600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13046-015-0135-8","type":"journal-article","created":{"date-parts":[[2015,2,27]],"date-time":"2015-02-27T12:00:45Z","timestamp":1425038445000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["DEC2 expression is positively correlated with HIF-1 activation and the invasiveness of human osteosarcomas"],"prefix":"10.1186","volume":"34","author":[{"given":"Tu","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nengbin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunsong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengqian","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nianli","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingcheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,28]]},"reference":[{"key":"135_CR1","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.jprot.2013.07.022","volume":"91","author":"D Kubota","year":"2013","unstructured":"Kubota D, Mukaihara K, Yoshida A, Tsuda H, Kawai A, Kondo T. Proteomics study of open biopsy samples identifies peroxiredoxin 2 as a predictive biomarker of response to induction chemotherapy in osteosarcoma. J Proteomics. 2013;91:393\u2013404.","journal-title":"J Proteomics"},{"issue":"15","key":"135_CR2","doi-asserted-by":"publisher","first-page":"5967","DOI":"10.7314\/APJCP.2014.15.15.5967","volume":"15","author":"JP He","year":"2014","unstructured":"He JP, Hao Y, Wang XL, Yang XJ, Shao JF, Guo FJ, et al. Review of the molecular pathogenesis of osteosarcoma. Asian Pac J Canc Prev. 2014;15(15):5967\u201376.","journal-title":"Asian Pac J Canc Prev"},{"issue":"5","key":"135_CR3","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1002\/cncr.21263","volume":"104","author":"V Mialou","year":"2005","unstructured":"Mialou V, Philip T, Kalifa C, Perol D, Gentet JC, Marec-Berard P, et al. Metastatic osteosarcoma at diagnosis: prognostic factors and long-term outcome\u2013the French pediatric experience. Cancer. 2005;104(5):1100\u20139.","journal-title":"Cancer"},{"issue":"6","key":"135_CR4","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.1007\/s13277-013-0966-x","volume":"34","author":"HL Fu","year":"2013","unstructured":"Fu HL, Shao L, Wang Q, Jia T, Li M, Yang DP. A systematic review of p53 as a biomarker of survival in patients with osteosarcoma. Tumour Biol. 2013;34(6):3817\u201321.","journal-title":"Tumour Biol"},{"issue":"6","key":"135_CR5","first-page":"409","volume":"85","author":"Q Wu","year":"2005","unstructured":"Wu Q, Yang SH, Ye SN, Wang RY. Therapeutic effects of RNA interference targeting HIF-1alpha gene on human osteosarcoma]. Chin J Med [Zhonghua Yi Xue Za Zhi]. 2005;85(6):409\u201313.","journal-title":"Chin J Med [Zhonghua Yi Xue Za Zhi]"},{"key":"135_CR6","first-page":"197946","volume":"2011","author":"S Chen","year":"2011","unstructured":"Chen S, Sang N. Histone deacetylase inhibitors: the epigenetic therapeutics that repress hypoxia-inducible factors. J Biomed Biotechnol. 2011;2011:197946.","journal-title":"J Biomed Biotechnol"},{"issue":"2","key":"135_CR7","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.bbrc.2013.12.020","volume":"443","author":"DD Cheng","year":"2014","unstructured":"Cheng DD, Zhao HG, Yang YS, Hu T, Yang QC. GSK3beta negatively regulates HIF1alpha mRNA stability via nucleolin in the MG63 osteosarcoma cell line. Biochem Bioph Res Co. 2014;443(2):598\u2013603.","journal-title":"Biochem Bioph Res Co"},{"issue":"1","key":"135_CR8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.critrevonc.2005.12.003","volume":"59","author":"K Hirota","year":"2006","unstructured":"Hirota K, Semenza GL. Regulation of angiogenesis by hypoxia-inducible factor 1. Crit Rew Oncol Hematol. 2006;59(1):15\u201326.","journal-title":"Crit Rew Oncol Hematol"},{"issue":"9","key":"135_CR9","doi-asserted-by":"publisher","first-page":"2984","DOI":"10.1128\/MCB.22.9.2984-2992.2002","volume":"22","author":"N Sang","year":"2002","unstructured":"Sang N, Fang J, Srinivas V, Leshchinsky I, Caro J. Carboxyl-terminal transactivation activity of hypoxia-inducible factor 1 alpha is governed by a von Hippel-Lindau protein-independent, hydroxylation-regulated association with p300\/CBP. Mol Cell Biol. 2002;22(9):2984\u201392.","journal-title":"Mol Cell Biol"},{"issue":"5","key":"135_CR10","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1158\/0008-5472.CAN-06-3985","volume":"67","author":"DP Stiehl","year":"2007","unstructured":"Stiehl DP, Fath DM, Liang D, Jiang Y, Sang N. Histone deacetylase inhibitors synergize p300 autoacetylation that regulates its transactivation activity and complex formation. Cancer Res. 2007;67(5):2256\u201364.","journal-title":"Cancer Res"},{"issue":"33","key":"135_CR11","doi-asserted-by":"publisher","first-page":"22785","DOI":"10.1074\/jbc.M114.587493","volume":"289","author":"S Joshi","year":"2014","unstructured":"Joshi S, Singh AR, Durden DL. MDM2 regulates hypoxic hypoxia-inducible factor 1alpha stability in an E3 ligase, proteasome, and PTEN-phosphatidylinositol 3-kinase-AKT-dependent manner. J Biol Chem. 2014;289(33):22785\u201397.","journal-title":"J Biol Chem"},{"key":"135_CR12","doi-asserted-by":"crossref","unstructured":"Joshi S, Singh AR, Durden DL. Pan-PI-3 kinase inhibitor SF1126 shows antitumor and antiangiogenic activity in renal cell carcinoma. Cancer Chemoth Pharm 2015 Epub ahead of print.","DOI":"10.1007\/s00280-014-2639-x"},{"issue":"16","key":"135_CR13","doi-asserted-by":"publisher","first-page":"14013","DOI":"10.1074\/jbc.M209702200","volume":"278","author":"N Sang","year":"2003","unstructured":"Sang N, Stiehl DP, Bohensky J, Leshchinsky I, Srinivas V, Caro J. MAPK signaling up-regulates the activity of hypoxia-inducible factors by its effects on p300. J Biol Chem. 2003;278(16):14013\u20139.","journal-title":"J Biol Chem"},{"issue":"24","key":"135_CR14","doi-asserted-by":"publisher","first-page":"4530","DOI":"10.4161\/cc.22820","volume":"11","author":"I Amelio","year":"2012","unstructured":"Amelio I, Melino G. The \u201cSharp\u201d blade against HIF-mediated metastasis. Cell cycle (Georgetown, Tex). 2012;11(24):4530\u20135.","journal-title":"Cell cycle (Georgetown, Tex)"},{"issue":"16","key":"135_CR15","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1002\/cncr.24438","volume":"115","author":"RA Figlin","year":"2009","unstructured":"Figlin RA, de Souza P, McDermott D, Dutcher JP, Berkenblit A, Thiele A, et al. Analysis of PTEN and HIF-1alpha and correlation with efficacy in patients with advanced renal cell carcinoma treated with temsirolimus versus interferon-alpha. Cancer. 2009;115(16):3651\u201360.","journal-title":"Cancer"},{"issue":"2","key":"135_CR16","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1200\/JCO.2007.13.7083","volume":"27","author":"D Generali","year":"2009","unstructured":"Generali D, Buffa FM, Berruti A, Brizzi MP, Campo L, Bonardi S, et al. Phosphorylated ERalpha, HIF-1\u03b1, and MAPK signaling as predictors of primary endocrine treatment response and resistance in patients with breast cancer. J Clin Oncol. 2009;27(2):227\u201334.","journal-title":"J Clin Oncol"},{"issue":"2","key":"135_CR17","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/jjco\/hyl137","volume":"37","author":"QC Yang","year":"2007","unstructured":"Yang QC, Zeng BF, Dong Y, Shi ZM, Jiang ZM, Huang J. Overexpression of hypoxia-inducible factor-1alpha in human osteosarcoma: correlation with clinicopathological parameters and survival outcome. Jpn J Clin Oncol. 2007;37(2):127\u201334.","journal-title":"Jpn J Clin Oncol"},{"issue":"22","key":"135_CR18","doi-asserted-by":"publisher","first-page":"20098","DOI":"10.1074\/jbc.M210427200","volume":"278","author":"S Azmi","year":"2003","unstructured":"Azmi S, Sun H, Ozog A, Taneja R. mSharp-1\/DEC2, a basic helix-loop-helix protein functions as a transcriptional repressor of E box activity and Stra13 expression. J Biol Chem. 2003;278(22):20098\u2013109.","journal-title":"J Biol Chem"},{"issue":"1\u20132","key":"135_CR19","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0925-4773(02)00049-7","volume":"114","author":"S Azmi","year":"2002","unstructured":"Azmi S, Taneja R. Embryonic expression of mSharp-1\/mDEC2, which encodes a basic helix-loop-helix transcription factor. Mech Develop. 2002;114(1\u20132):181\u20135.","journal-title":"Mech Develop"},{"issue":"3","key":"135_CR20","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s10549-010-1083-9","volume":"128","author":"Y Li","year":"2011","unstructured":"Li Y, Shen Q, Kim HT, Bissonnette RP, Lamph WW, Yan B, et al. The rexinoid bexarotene represses cyclin D1 transcription by inducing the DEC2 transcriptional repressor. Breast Cancer Res TR. 2011;128(3):667\u201377.","journal-title":"Breast Cancer Res TR"},{"issue":"4","key":"135_CR21","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1365-2443.2010.01381.x","volume":"15","author":"Y Liu","year":"2010","unstructured":"Liu Y, Sato F, Kawamoto T, Fujimoto K, Morohashi S, Akasaka H, et al. Anti-apoptotic effect of the basic helix-loop-helix (bHLH) transcription factor DEC2 in human breast cancer cells. Genes Cells. 2010;15(4):315\u201325.","journal-title":"Genes Cells"},{"issue":"7407","key":"135_CR22","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nature11207","volume":"487","author":"M Montagner","year":"2012","unstructured":"Montagner M, Enzo E, Forcato M, Zanconato F, Parenti A, Rampazzo E, et al. SHARP1 suppresses breast cancer metastasis by promoting degradation of hypoxia-inducible factors. Nature. 2012;487(7407):380\u20134.","journal-title":"Nature"},{"issue":"6","key":"135_CR23","doi-asserted-by":"publisher","first-page":"e99907","DOI":"10.1371\/journal.pone.0099907","volume":"9","author":"Y Liao","year":"2014","unstructured":"Liao Y, Lu W, Che Q, Yang T, Qiu H, Zhang H, et al. SHARP1 suppresses angiogenesis of endometrial cancer by decreasing hypoxia-inducible factor-1alpha level. PLoS ONE. 2014;9(6):e99907.","journal-title":"PLoS ONE"},{"issue":"2","key":"135_CR24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.1365-2443.2007.01153.x","volume":"13","author":"F Sato","year":"2008","unstructured":"Sato F, Bhawal UK, Kawamoto T, Fujimoto K, Imaizumi T, Imanaka T, et al. Basic-helix-loop-helix (bHLH) transcription factor DEC2 negatively regulates vascular endothelial growth factor expression. Genes Cells. 2008;13(2):131\u201344.","journal-title":"Genes Cells"},{"issue":"2","key":"135_CR25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2220\/biomedres.33.75","volume":"33","author":"Y Wu","year":"2012","unstructured":"Wu Y, Sato F, Bhawal UK, Kawamoto T, Fujimoto K, Noshiro M, et al. BHLH transcription factor DEC2 regulates pro-apoptotic factor Bim in human oral cancer HSC-3 cells. Biomed Res (Tokyo, Japan). 2012;33(2):75\u201382.","journal-title":"Biomed Res (Tokyo, Japan)"},{"issue":"4929","key":"135_CR26","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1126\/science.2814477","volume":"246","author":"MP King","year":"1989","unstructured":"King MP, Attardi G. Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. Science. 1989;246(4929):500\u20133.","journal-title":"Science"},{"issue":"3","key":"135_CR27","doi-asserted-by":"publisher","first-page":"e1000879","DOI":"10.1371\/journal.pgen.1000879","volume":"6","author":"J Tie","year":"2010","unstructured":"Tie J, Pan Y, Zhao L, Wu K, Liu J, Sun S, et al. MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor. PLoS Genet. 2010;6(3):e1000879.","journal-title":"PLoS Genet"},{"issue":"15","key":"135_CR28","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1038\/sj.onc.1210864","volume":"27","author":"PL Torng","year":"2008","unstructured":"Torng PL, Lee YC, Huang CY, Ye JH, Lin YS, Chu YW, et al. Insulin-like growth factor binding protein-3 (IGFBP-3) acts as an invasion-metastasis suppressor in ovarian endometrioid carcinoma. Oncogene. 2008;27(15):2137\u201347.","journal-title":"Oncogene"},{"key":"135_CR29","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1756-9966-33-26","volume":"33","author":"S Lin","year":"2014","unstructured":"Lin S, Guo Q, Wen J, Li C, Lin J, Cui X, et al. Survival analyses correlate stanniocalcin 2 overexpression to poor prognosis of nasopharyngeal carcinomas. J Exp Clin Canc Res. 2014;33:26.","journal-title":"J Exp Clin Canc Res"},{"issue":"3","key":"135_CR30","first-page":"707","volume":"21","author":"T Ishikawa","year":"2009","unstructured":"Ishikawa T, Nakashiro K, Klosek SK, Goda H, Hara S, Uchida D, et al. Hypoxia enhances CXCR4 expression by activating HIF-1 in oral squamous cell carcinoma. Oncol Rep. 2009;21(3):707\u201312.","journal-title":"Oncol Rep"},{"issue":"8","key":"135_CR31","doi-asserted-by":"publisher","first-page":"6183","DOI":"10.1074\/jbc.M110978200","volume":"277","author":"A Minchenko","year":"2002","unstructured":"Minchenko A, Leshchinsky I, Opentanova I, Sang N, Srinivas V, Armstead V, et al. Hypoxia-inducible factor-1-mediated expression of the 6-phosphofructo-2-kinase\/fructose-2,6-bisphosphatase-3 (PFKFB3) gene. Its possible role in the Warburg effect. J Biol Chem. 2002;277(8):6183\u20137.","journal-title":"J Biol Chem"},{"issue":"11","key":"135_CR32","doi-asserted-by":"publisher","first-page":"e80544","DOI":"10.1371\/journal.pone.0080544","volume":"8","author":"T Zhang","year":"2013","unstructured":"Zhang T, Niu X, Liao L, Cho EA, Yang H. The contributions of HIF-target genes to tumor growth in RCC. PLoS ONE. 2013;8(11):e80544.","journal-title":"PLoS ONE"},{"issue":"1","key":"135_CR33","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/labinvest.3700003","volume":"84","author":"KV Lu","year":"2004","unstructured":"Lu KV, Jong KA, Rajasekaran AK, Cloughesy TF, Mischel PS. Upregulation of tissue inhibitor of metalloproteinases (TIMP)-2 promotes matrix metalloproteinase (MMP)-2 activation and cell invasion in a human glioblastoma cell line. Lab Invest. 2004;84(1):8\u201320.","journal-title":"Lab Invest"},{"issue":"9","key":"135_CR34","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1007\/s11999-008-0335-z","volume":"466","author":"N Tang","year":"2008","unstructured":"Tang N, Song WX, Luo J, Haydon RC, He TC. Osteosarcoma development and stem cell differentiation. Clin Orthop Relat R. 2008;466(9):2114\u201330.","journal-title":"Clin Orthop Relat R"},{"issue":"2","key":"135_CR35","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1615\/CritRevEukarGeneExpr.v5.i2.20","volume":"5","author":"TK MacLachlan","year":"1995","unstructured":"MacLachlan TK, Sang N, Giordano A. Cyclins, cyclin-dependent kinases and cdk inhibitors: implications in cell cycle control and cancer. Crit Rev Eukar Gene. 1995;5(2):127\u201356.","journal-title":"Crit Rev Eukar Gene"},{"issue":"1","key":"135_CR36","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1615\/CritRevEukarGeneExpr.v22.i1.20","volume":"22","author":"C Yin","year":"2012","unstructured":"Yin C, Qie S, Sang N. Carbon source metabolism and its regulation in cancer cells. Crit Rev Eukar Gene. 2012;22(1):17\u201335.","journal-title":"Crit Rev Eukar Gene"},{"issue":"2","key":"135_CR37","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1182\/blood-2004-07-2958","volume":"105","author":"DJ Manalo","year":"2005","unstructured":"Manalo DJ, Rowan A, Lavoie T, Natarajan L, Kelly BD, Ye SQ, et al. Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood. 2005;105(2):659\u201369.","journal-title":"Blood"},{"key":"135_CR38","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1756-9966-29-43","volume":"29","author":"X Hu","year":"2010","unstructured":"Hu X, Yu AX, Qi BW, Fu T, Wu G, Zhou M, et al. The expression and significance of IDH1 and p53 in osteosarcoma. J Exp Clin Canc Res. 2010;29:43.","journal-title":"J Exp Clin Canc Res"},{"issue":"4","key":"135_CR39","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.molcel.2008.04.009","volume":"30","author":"WG Kaelin Jr","year":"2008","unstructured":"Kaelin Jr WG, Ratcliffe PJ. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell. 2008;30(4):393\u2013402.","journal-title":"Mol Cell"},{"issue":"3","key":"135_CR40","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1165\/ajrcmb.17.3.2837","volume":"17","author":"YW Chu","year":"1997","unstructured":"Chu YW, Yang PC, Yang SC, Shyu YC, Hendrix MJ, Wu R, et al. Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line. Am J Resp Cell Mol. 1997;17(3):353\u201360.","journal-title":"Am J Resp Cell Mol"},{"issue":"6","key":"135_CR41","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1128\/MCB.26.6.2019-2028.2006","volume":"26","author":"X Kong","year":"2006","unstructured":"Kong X, Lin Z, Liang D, Fath D, Sang N, Caro J. Histone deacetylase inhibitors induce VHL and ubiquitin-independent proteasomal degradation of hypoxia-inducible factor 1\u03b1. Mol Cell Biol. 2006;26(6):2019\u201328.","journal-title":"Mol Cell Biol"},{"issue":"4","key":"135_CR42","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1002\/jcp.22870","volume":"227","author":"T Lao","year":"2012","unstructured":"Lao T, Chen S, Sang N. Two mutations impair the stability and function of ubiquitin-activating enzyme (E1). J Cell Physiol. 2012;227(4):1561\u20138.","journal-title":"J Cell Physiol"},{"issue":"49","key":"135_CR43","doi-asserted-by":"publisher","first-page":"47014","DOI":"10.1074\/jbc.M204938200","volume":"277","author":"K Miyazaki","year":"2002","unstructured":"Miyazaki K, Kawamoto T, Tanimoto K, Nishiyama M, Honda H, Kato Y. Identification of functional hypoxia response elements in the promoter region of the DEC1 and DEC2 genes. J Biol Chem. 2002;277(49):47014\u201321.","journal-title":"J Biol Chem"}],"container-title":["Journal of Experimental & Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-015-0135-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13046-015-0135-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-015-0135-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-015-0135-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T09:00:56Z","timestamp":1630573256000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-015-0135-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,28]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["135"],"URL":"https:\/\/doi.org\/10.1186\/s13046-015-0135-8","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,28]]},"assertion":[{"value":"15 January 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"22"}}